A study by Interleukin Genetics Inc. shows that women are more likely to suffer vertebral fractures and osteoporosis if they carry a specific gene variation.
The Waltham-based biomarker maker, which is flirting with a de-listing by the New York Stock Exchange, said its clinical study of 1,200 Asian women that Korean women are 70 percent more disposed to vertebral fracture if they carry a genetic variation in the IL-10 gene.